| 摘要 |
FIELD: medicine, hematology. ^ SUBSTANCE: method consists in long-term complex administration of low-calorie diet, 200 mg of labetalole twice a day, and 2 mg of lacidipine every morning, to correct platelet hemostasis in metabolic syndrome patients. The method allows primary hemostasis normalisation in metabolic syndrome patients during 2 months, due to ADP and ATP levels normalisation, as well as actin and myosin level and assemblage normalisation in platelets. ^ EFFECT: primary hemostasis normalisation in metabolic syndrome patients. ^ 1 ex |
